Data / Form D filings / Treysta Medical Technologies Inc.
Treysta Medical Technologies Inc.: Form D filings
Treysta Medical Technologies Inc., a biotechnology company in Gainesille, FL, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on February 17, 2026, reports $90,000 sold of a $300,000 offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3733 NORTHWEST 53RD LANE, Gainesille, FL, 32653
- Phone
- (608) 770-0658
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2057780
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | New notice | $300,000 | $90,000 | $210,000 | 5 | Jan 19, 2026 | sec.gov |
| Apr 10, 2025 | New notice | $150,000 | $92,500 | $57,500 | 5 | Apr 4, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nathan Zarnstorff | Executive Officer, Director | |
| Marcelo Buzzi | Executive Officer, Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Feb 16, 2026 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Treysta Medical Technologies Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.